Tabs
Subprojects 1 and 2
Tobias Gerhard PhD, MSc; Rutgers University Institute for Health, New Brunswick, NJ
Marsha Raebel PharmD; Kaiser Permanente Colorado, Denver, CO
Subproject 3
Ann W. McMahon MD, MS; Office of Pediatric Therapeutics, Office of the Commissioner, FDA, Silver Spring, MD
Robert Penfold PhD; Group Health Research Institute, Seattle, WA
Diqiong Xie PhD; Center for Drug Evaluation and Research, FDA, Silver Spring, MD
Melissa L Andersen MSc; J. Gene Hart MSc; Susan Shortreed PhD; Group Health Research Institute, Seattle, WA
Susan Andrade ScD; Meyers Primary Care Institute, a joint endeavor of Fallon Community Health Plan, Reliant Medical Group, and University of Massachusetts Medical School, Worcester, MA
William Bobo MD, MPH; Vanderbilt University School of Medicine, Nashville, TN
Chadi Calarge MD; Jess Fiedorowicz MD, PhD; University of Iowa, College of Medicine, Iowa City, IA
Christoph Correll MD; Stephen Crystal PhD; Rutgers University Institute for Health, New Brunswick, NJ
Kristin Goddard MPH; Susan Shetterly MS; Kaiser Permanente Colorado, Denver, CO
Christine Y. Lu PhD, MSc; Darren Toh ScD; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
Ali Mohamadi MD; Simone Pinheiro ScD, MSc; Marsha Reichman PhD; Center for Drug Evaluation and Research, FDA, Silver Spring, MD
Zhiying You MD, PhD; University of Alabama at Birmingham, Birmingham, AL